Bispecific CD20-directed CD3 T Cell Engager class drugs

FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

1 result

Columvi (glofitamab)

(Glofitamab)

Manufacturer:Genentech, Inc.

Usage: COLUMVI is indicated for treating adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or large B-cell lymphoma from follicular lymphoma, following two or more systemic therapies. Its approval is based on response rates, with continued approval pending clinical benefit confirmation.